LIC MF Healthcare Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 16-07-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
LIC MF Healthcare Fund-Regular Plan-Growth 4.08 9.78 43.91 10.43 21.60 19.52
BSE Health Care - TRI 4.03 11.29 48.75 14.97 25.26 15.74
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
LIC MF Healthcare Fund-Regular Plan-Growth Feb 28, 2019 43.91 10.43 21.60 2.44 62.03
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 43.61 14.44 26.76 1.82 7,404.21
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 38.72 16.38 27.62 2.00 2,760.05
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 44.48 16.74 28.81 1.98 2,479.25
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 45.11 14.56 28.02 1.97 2,312.48
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 47.81 13.56 25.61 2.28 985.80

Fund Holdings as on 30-June-2024

  • Sun Pharmaceutical Industries Ltd.

  • Piramal Pharma Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Glenmark Pharmaceuticals Ltd.

  • Cipla Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Mankind Pharma Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Zydus Lifesciences Ltd.

  • Artemis Medicare Services Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Abbott India Ltd.

  • Divi's Laboratories Ltd.

  • IPCA Laboratories Ltd.

  • Alkem Laboratories Ltd.

  • Global Health Ltd.

  • Laurus Labs Ltd.

  • Metropolis Healthcare Ltd.

  • Neogen Chemicals Ltd.

  • Treps

  • Suven Pharmaceuticals Ltd.

  • Syngene International Ltd.

  • Net Receivables / (Payables)

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Chemicals

  • Miscellaneous

  • Business Support

View More

Fund Manager

  • Cash

  • Equity

View More

About LIC MF Healthcare Fund

Scheme Analysis

LIC MF Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to LIC Mutual Fund. It was launched on 28-Feb-2019 and currently has an AUM of ₹62.03 crore. LIC MF Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of LIC MF Healthcare Fund ended down ₹-0.11(-0.42%)yesterday to ₹25.9952.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The LIC MF Healthcare Fund is managed by Karan Doshi .

Fund House Contact

4th Floor, Industrial Assurance Building, Opp. Churchgate Station, Mumbai - 400 020

022-66016000
service@licnomuramf.com
022-22880633